Neostigmine Bromide structure
|
Common Name | Neostigmine Bromide | ||
|---|---|---|---|---|
| CAS Number | 114-80-7 | Molecular Weight | 303.195 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H19BrN2O2 | Melting Point | 175-177 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS06, GHS08 |
Signal Word | Danger | |
Use of Neostigmine BromideNeostigmine Bromide is a cholinesterase inhibitor used in the treatment of myasthenia gravis.Target: CholinesteraseNeostigmine is a parasympathomimetic that acts as a reversible acetylcholinesterase inhibitor. Neostigmine enhances excitatory parasympathetic activity by competing with acetylcholine for attachment to acetylcholinesterase at sites of cholinergic transmission and enhancing cholinergic action. Neostigmine is a safe and effective treatment for acute colonic pseudo-obstruction [1]. |
| Name | neostigmine bromide |
|---|---|
| Synonym | More Synonyms |
| Description | Neostigmine Bromide is a cholinesterase inhibitor used in the treatment of myasthenia gravis.Target: CholinesteraseNeostigmine is a parasympathomimetic that acts as a reversible acetylcholinesterase inhibitor. Neostigmine enhances excitatory parasympathetic activity by competing with acetylcholine for attachment to acetylcholinesterase at sites of cholinergic transmission and enhancing cholinergic action. Neostigmine is a safe and effective treatment for acute colonic pseudo-obstruction [1]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 175-177 °C(lit.) |
|---|---|
| Molecular Formula | C12H19BrN2O2 |
| Molecular Weight | 303.195 |
| Exact Mass | 302.062988 |
| PSA | 29.54000 |
| Water Solubility | 1 g/ mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300 + H310 + H330-H315-H317-H319-H334-H335 |
| Precautionary Statements | Missing Phrase - N15.00950417-P260-P280-P284-P302 + P352 + P310-P304 + P340 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T: Toxic;T+: Very toxic; |
| Risk Phrases | R25;R36/37/38;R42/43 |
| Safety Phrases | 22-26-36/37/39-45-37/39-28A |
| RIDADR | UN 2811 6.1/PG 2 |
| WGK Germany | 3 |
| RTECS | BR3150000 |
| Packaging Group | II |
| Hazard Class | 6.1(a) |
| HS Code | 2924299090 |
|
~%
Neostigmine Bromide CAS#:114-80-7 |
| Literature: CH208883 , ; |
|
~%
Neostigmine Bromide CAS#:114-80-7 |
| Literature: CH208883 , ; |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients.
Clin. Chem. Lab Med. 53 , 1259-64, (2015) Physostigmine, commonly used as an antidote in anticholinergic poisoning, is reported to have additional pharmacological effects, such as activation of the cholinergic anti-inflammatory pathway in sep... |
|
|
Microwave-assisted synthesis, molecular docking, and cholinesterase inhibitory activities of new ethanediamide and 2-butenediamide analogues.
Chem. Pharm. Bull. 63(3) , 210-7, (2015) A novel series of meta-substituted ethanediamide and 2-butenediamide derivatives were synthesized and tested for their ability to inhibit electric eel acetylcholinesterase (AChE) and equine serum buty... |
|
|
Alterations in gills of Lepomis gibbosus, after acute exposure to several xenobiotics (pesticide, detergent and pharmaceuticals): morphometric and biochemical evaluation.
Drug Chem. Toxicol. 38 , 126-32, (2015) In recent decades, scientific research about the effects of anthropogenic xenobiotics on non-target organisms has increased. Among the likely effects, some studies reported the evaluation of biochemic... |
| Neostigmin |
| stigmanolbromide |
| Prostigmi |
| Vagostigmine bromide |
| Neoesserin |
| Prostigmin bromide |
| stigmosanbromide |
| 3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide,Prostigmine |
| (3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide |
| neoserinebromide |
| MFCD00011795 |
| prostigmin |
| Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide (1:1) |
| EINECS 204-054-8 |
| Vagostigmin bromide |
| 3-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide |
| (3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate |
| PROSTIGMINE |
| 3-Dimethylcarbamoyloxy-tri-N-methyl-anilinium,Bromid |
| 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide |
| Juvastigmin |
| 3-dimethylcarbamoyloxy-tri-N-methyl-anilinium,bromide |
| eustigminbromide |
| Neostigmine Bromide |
| Neostigmine (Bromide) |